BioTek offers many peripheral instruments and accessories to expand functionality and enhance assay workflows. Many peripheral instruments and modules are compatible with several different instruments, see the list here.

BioTek's highly trained sales and service professionals are experts in life science instrumentation. They will guide you through your decision process and help you select the proper equipment for your application, assist with installation in your lab, and train your staff on the use of the instrumentation.

November 14, 2018 - BioTek Instruments extends congratulations to Dr. Benjamin R. King as this year’s recipient of the Norman R. Alpert Research Prize. The honor, which includes an engraved plaque and cash award, was announced at the Larner College of Medicine Research Day event held at The University of Vermont (UVM) on October 30, 2018. Weiterlesen

October 22, 2018 - BioTek is pleased to congratulate its President and CEO, Briar Alpert, for receiving the 2018 Alumni Achievement Award from the University of Vermont (UVM) Alumni Association. The award recognizes alumni demonstrating outstanding commitment to Vermont, the University, and the local community. Weiterlesen

October 16, 2018 - BioTek has released a Peltier Cooling Module for the Cytation™ Cell Imaging Multi-Mode Readers. The compact module keeps internal temperature rise to less than one degree over ambient, regardless of fluctuations from external and internal factors. The module helps maintain and optimize stability for more consistent data in assays run at ambient temperature. The module also quickly reduces internal temperature after incubated assays for efficient transitions between multiple applications with different temperature requirements. Weiterlesen

March 2 - 6, 2019

Booth #404

Baltimore Convention Center

Nothing can speak to the experience you'll encounter with BioTek like stories from our customers themselves. Customer satisfaction is our top priority. From Engineering to Manufacturing to Sales and Support, BioTek employees around the world are dedicated to providing the best product and best customer experience in the industry.

At BioTek we feel passionately and genuinely that our employees are our greatest asset. We continue to build our already impressive team having doubled our global workforce in the last five years. With our headquarters in the beautiful Green Mountains of Vermont, USA, we also have regional offices around the world.

If you're interested in becoming part of our amazing team, check out our list of job openings today!

As a prospective partner, BioTek can help you achieve your sales and market penetration by providing a unique blend of products, service, support, training, co-marketing and quality assurance designed to meet your customers’ requirements while you remain focused on your core business.

At BioTek we feel passionately and genuinely that our employees are our greatest asset. We continue to build our already impressive team having doubled our global workforce in the last five years. With our headquarters in the beautiful Green Mountains of Vermont, USA, we also have regional offices around the world.

If you're interested in becoming part of our amazing team, check out our list of job openings today!

Quellen -
Anwendungshinweise

LanthaScreen™ TR-FRET Assay from Invitrogen on Synergy 4

Introduction

Here we describe the use of the Synergy 4 Hybrid Microplate Reader to measure the output from Invitrogen's LanthaScreen™ TR-FRET assay technology.

LanthaScreen™ technology uses time-resolved fluorescence resonance energy transfer (TR-FRET) to study multiple target classes including protein kinases, nuclear hormone receptors, as well as proteases and ubiquitinated proteins. LanthaScreen™ TR-FRET works on the principles that when suitable pairs of fluorophores are in close proximity of one another, excitation of the terbium chelate donor fluorophore results in energy transfer to the fluorescein or GFP acceptor fluorophore (Figure 1). The benefit of this assay is the long fluorescence lifetime of the terbium lanthanide donor fluor excited at 340 nm. This allows measurement of the signal long after the background fluorescence has dissipated (Figure 2). The time-resolved measurement reduces assay interference (e.g. fluorescent compounds) and increases data quality.

Materials and Methods

A LanthaScreen™ Tb-anti-GST Antibody Kit (catalog number PV4216) was obtained from Invitrogen (Carlsbad, CA). Solid white 384-well (catalog number 3912) and 1536-well (catalog number 3725) microplates were purchased from Corning (Corning, NY). The assay was performed according to the kit instructions. Briefly, the fluorescein labeled GST-MBP positive control provided was serially diluted from 200nM, and the Tb-anti-GST antibody was diluted to 4 nM using the LanthaScreen™ TR-FRET dilution buffer provided. For reactions in 384-well plates 20 µL of Tb-anti-GST antibody (2nM final) and 20 µL of the fluorescein-GST-MBP positive control dilution were aliquoted in replicates of 8. Reactions in 1536-well plates contained 5 µL of antibody and 5 µL of positive control. The reactions were allowed to incubate for 60 minutes in the dark at room temperature. The plates were then read on a Synergy 4 Multi-Mode Microplate Reader, using the reader's filter system. The reader was controlled and the data collected and analyzed using Gen5 Data Analysis Software.

Results

The emission spectrum data presented in Figure 2 indicates that the fluorescein acceptor emission is a narrow band centered around 520 nm when excited at 340 nm, and typical fluorescein emission filters at 530 or 535 nm are not suitable for detection. Samples with only terbium-labeled antibody exhibit a narrow band emission centered around 495 nm. Using a suitable emission filter set for wavelength selection as on the Synergy 4 Hybrid Reader, the fluorescein emission can be distinguished from that of terbium.

The data presented in Figures 3 and 4 demonstrate the ability of the Synergy 4 Hybrid Reader to quantitatively measure TR-FRET signal using the Invitrogen LanthaScreen™ assay in either 384- or 1536-well plates. When the signal-to-background ratio is plotted against fluorescein-GST-MBP concentration a sigmoidal shaped curve is observed. This sigmoidal relationship can be described using a 4-parameter logistic fit of the data.